Tissue Extraction Devices Retains IPinvestments Group to Commercialize its Intellectual Property Portfolio Related to Biopsy Devices

INDIANAPOLIS & ATLANTA--(BUSINESS WIRE)--Tissue Extraction Devices, LLC, a privately held Indianapolis-based company focused on developing innovative medical devices, today announced that the company has advanced their strategic intellectual property initiative by retaining IPinvestments Group, an intellectual property business advisory firm, to market Tissue Extraction Device’s medical device technology (“IP Portfolio”). The IP Portfolio consists of four (4) allowed and pending U.S. Patent applications and a pending interference action filed with the U.S. Patent and Trademark Office against U.S. Patent No. 6,758,824 (assigned to Suros Surgical Systems, Inc. which is now part of Hologic, Inc.).